Inhibition of L-Type Amino Acid Transporter Modulates the Expression of Cell Cycle Regulatory Factors in KB Oral Cancer Cells
-
- Kim Chun Sung
- Department of Oralbiochemistry, Chosun University School of Dentistry
-
- Moon In-Sung
- Oral Biology Research Institute, Chosun University School of Dentistry
-
- Park Ju-Hyun
- Oral Biology Research Institute, Chosun University School of Dentistry
-
- Shin Woo-Cheol
- Oral Biology Research Institute, Chosun University School of Dentistry
-
- Chun Hong Sung
- Department of Biotechnology (BK21 Program), Chosun University
-
- Lee Sook-Young
- Research Center for Oral Disease Regulation of the Aged, Chosun University School of Dentistry
-
- Kook Joong-Ki
- Department of Oralbiochemistry, Chosun University School of Dentistry
-
- Kim Heung-Joong
- Oral Biology Research Institute, Chosun University School of Dentistry
-
- Park Joo-Cheol
- Department of Oral Histology and Developmental Biology, Seoul National University School of Dentistry
-
- Endou Hitoshi
- Department of Pharmacology and Toxicology, Kyorin University School of Medicine
-
- Kanai Yoshikatsu
- Department of Pharmacology, Osaka University Graduate School of Medicine
-
- Lee Byung-Kwon
- Department of Microbiology, University of Tennessee
-
- Kim Do Kyung
- Oral Biology Research Institute, Chosun University School of Dentistry
この論文をさがす
抄録
The purpose of this study was to examine the effect of 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid (BCH), an inhibitor of L-type amino acid transporters, on the cell growth suppression in KB human oral cancer cells and to study the roles of cell cycle regulatory factors in the BCH-induced growth inhibition. The effect of BCH on cell growth suppression and the influence of BCH to cell cycle regulatory factors in KB cell growth inhibition were examined using cell cycle analysis, immunoblotting and immunoprecipitation. The BCH treatment induced cell cycle arrest at G1 phase in KB cells. The expression of cyclin D3 was remarkably decreased by BCH treatment. The BCH inhibited the expression of cyclin-dependent protein kinase 6 (CDK6) in a time-dependent manner. In addition, the expression of CDK inhibitor p27 was increased by BCH treatment in KB cells, but not CDK inhibitors p21 and p15. These results suggest that, in KB cells, the inhibition of LAT1 by BCH causes cell cycle arrest at G1 phase by inhibiting cyclin D3–CDK6 complex whereas increasing expression of a CDK inhibitor p27.
収録刊行物
-
- Biological & Pharmaceutical Bulletin
-
Biological & Pharmaceutical Bulletin 33 (7), 1117-1121, 2010
公益社団法人 日本薬学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390282679604700416
-
- NII論文ID
- 130000300273
-
- NII書誌ID
- AA10885497
-
- COI
- 1:STN:280:DC%2BC3cnltFKguw%3D%3D
-
- ISSN
- 13475215
- 09186158
-
- NDL書誌ID
- 10738102
-
- PubMed
- 20606299
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可